Variant report

Variant	esv3366768
Chromosome Location	chr7:102613816-102618977
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:449)
CpG islands
(count:124)
Chromatin interactive
region (count:6)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:449 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:102615512-102615697	K562	blood:	n/a	n/a
2	ARID3A	chr7:102613385-102614106	K562	blood:	n/a	n/a
3	ARID3A	chr7:102618784-102618922	K562	blood:	n/a	n/a
4	ATF1	chr7:102618759-102618993	K562	blood:	n/a	n/a
5	ATF1	chr7:102613562-102614182	K562	blood:	n/a	n/a
6	ATF1	chr7:102615471-102615652	K562	blood:	n/a	n/a
7	ATF3	chr7:102613482-102614149	K562	blood:	n/a	n/a
8	BACH1	chr7:102613561-102613930	K562	blood:	n/a	n/a
9	BCLAF1	chr7:102613400-102614259	K562	blood:	n/a	n/a
10	BHLHE40	chr7:102613578-102614258	K562	blood:	n/a	n/a
11	BHLHE40	chr7:102615498-102615614	K562	blood:	n/a	n/a
12	BRCA1	chr7:102618851-102619385	Hela-S3	cervix:	n/a	n/a
13	CBX3	chr7:102616016-102616744	K562	blood:	n/a	n/a
14	CBX3	chr7:102613423-102614555	K562	blood:	n/a	n/a
15	CBX3	chr7:102618539-102619152	K562	blood:	n/a	n/a
16	CBX3	chr7:102615174-102615822	K562	blood:	n/a	n/a
17	CBX3	chr7:102613428-102614115	K562	blood:	n/a	n/a
18	CBX3	chr7:102616799-102617613	K562	blood:	n/a	n/a
19	CEBPB	chr7:102618669-102619280	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr7:102618699-102619116	K562	blood:	n/a	n/a
21	CEBPB	chr7:102618826-102619089	A549	lung:	n/a	n/a
22	CEBPB	chr7:102618532-102619398	HCT-116	colon:	n/a	n/a
23	CEBPB	chr7:102618789-102619150	A549	lung:	n/a	n/a
24	CEBPB	chr7:102613340-102614174	K562	blood:	n/a	n/a
25	CEBPB	chr7:102618666-102619360	HCT-116	colon:	n/a	n/a
26	CEBPB	chr7:102613488-102614107	K562	blood:	n/a	n/a
27	CEBPB	chr7:102618855-102619104	K562	blood:	n/a	n/a
28	CEBPB	chr7:102613646-102614034	K562	blood:	n/a	n/a
29	CEBPB	chr7:102618748-102619159	IMR90	lung:	n/a	n/a
30	CEBPD	chr7:102613402-102614386	K562	blood:	n/a	n/a
31	CHD2	chr7:102616910-102617141	K562	blood:	n/a	n/a
32	CHD2	chr7:102613905-102614176	K562	blood:	n/a	n/a
33	CHD2	chr7:102615129-102615353	K562	blood:	n/a	n/a
34	CHD2	chr7:102618728-102619216	Hela-S3	cervix:	n/a	n/a
35	CTCF	chr7:102615500-102615650	GM12872	blood:	n/a	n/a
36	CTCF	chr7:102615516-102615697	Gliobla	brain:	n/a	n/a
37	CTCF	chr7:102615302-102615753	A549	lung:	n/a	n/a
38	CTCF	chr7:102615540-102615690	NHEK	skin:	n/a	n/a
39	CTCF	chr7:102615460-102615610	HCT-116	colon:	n/a	n/a
40	CTCF	chr7:102615500-102615650	HPF	lung:	n/a	n/a
41	CTCF	chr7:102615520-102615670	HMF	breast:	n/a	n/a
42	CTCF	chr7:102615540-102615690	GM12864	blood:	n/a	n/a
43	CTCF	chr7:102615540-102615690	HFF-Myc	foreskin:	n/a	n/a
44	CTCF	chr7:102615540-102615690	WERI-Rb-1	eye:	n/a	n/a
45	CTCF	chr7:102615520-102615670	AG04449	skin:	n/a	n/a
46	CTCF	chr7:102615500-102615650	GM12865	blood:	n/a	n/a
47	CTCF	chr7:102615520-102615670	HPF	lung:	n/a	n/a
48	CTCF	chr7:102615480-102615630	NHEK	skin:	n/a	n/a
49	CTCF	chr7:102615520-102615670	GM12867	blood:	n/a	n/a
50	CTCF	chr7:102615500-102615650	HBMEC	blood vessel:	n/a	n/a

(count:124 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:102613822-102613872	HCF	heart:	n/a
2	chr7:102614121-102614171	SK-N-MC	brain:	n/a
3	chr7:102613822-102613872	HCF	heart:	n/a
4	chr7:102614121-102614171	SK-N-MC	brain:	n/a
5	chr7:102613822-102613872	HIPEpiC	eye:	n/a
6	chr7:102614121-102614171	ECC-1	luminal epithelium:	n/a
7	chr7:102613822-102613872	IMR90	lung:	fetal
8	chr7:102613822-102613872	AG09319	gingival:	n/a
9	chr7:102614121-102614171	A549	lung:	n/a
10	chr7:102614121-102614171	HL-60	blood:	n/a
11	chr7:102613822-102613872	HCPEpiC	choroid plexus:	n/a
12	chr7:102613822-102613872	SK-N-SH	brain:	n/a
13	chr7:102613822-102613872	SK-N-MC	brain:	n/a
14	chr7:102614121-102614171	AG10803	skin:	n/a
15	chr7:102614121-102614171	CMK	blood:	n/a
16	chr7:102614121-102614171	SK-N-SH_RA	brain:	n/a
17	chr7:102614121-102614171	BE2_C	brain:	n/a
18	chr7:102614121-102614171	GM19239	blood:	n/a
19	chr7:102613822-102613872	PANC-1	pancreas:	n/a
20	chr7:102614121-102614171	HRE	kidney:	n/a
21	chr7:102613822-102613872	BJ	skin:	n/a
22	chr7:102613822-102613872	SK-N-SH_RA	brain:	n/a
23	chr7:102614121-102614171	HMEC	breast:	n/a
24	chr7:102613822-102613872	AG04449	skin:	fetal
25	chr7:102613822-102613872	AG10803	skin:	n/a
26	chr7:102613822-102613872	HPAEpiC	pulmonary alveolar:	n/a
27	chr7:102613822-102613872	HMEC	breast:	n/a
28	chr7:102613822-102613872	HEEpiC	esophagus:	n/a
29	chr7:102613822-102613872	HCT-116	colon:	n/a
30	chr7:102614121-102614171	SAEC	small airway:	n/a
31	chr7:102613822-102613872	U87	brain:	n/a
32	chr7:102613822-102613872	PrEC	prostate:	n/a
33	chr7:102613822-102613872	NB4	blood:	n/a
34	chr7:102614121-102614171	LNCaP	prostate:	n/a
35	chr7:102614121-102614171	GM12892	blood:	n/a
36	chr7:102614121-102614171	AG04449	skin:	fetal
37	chr7:102613822-102613872	ProgFib	skin:	n/a
38	chr7:102614121-102614171	NB4	blood:	n/a
39	chr7:102613822-102613872	Caco-2	colon:	n/a
40	chr7:102614121-102614171	PrEC	prostate:	n/a
41	chr7:102614121-102614171	MCF-7	breast:	n/a
42	chr7:102614121-102614171	HCM	heart:	n/a
43	chr7:102613822-102613872	GM12892	blood:	n/a
44	chr7:102614121-102614171	AG09309	skin:	n/a
45	chr7:102614121-102614171	AoSMC	blood vessel:	n/a
46	chr7:102614121-102614171	BJ	skin:	n/a
47	chr7:102613822-102613872	K562	blood:	n/a
48	chr7:102614121-102614171	H1-hESC	embryonic stem cell:	embryo
49	chr7:102614121-102614171	SKMC	muscle:	n/a
50	chr7:102613822-102613872	BE2_C	brain:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:102452440..102454909-chr7:102615064..102617723,2	K562	blood:
2	chr7:102497060..102498758-chr7:102613043..102615053,2	K562	blood:
3	chr7:102613006..102614516-chr7:102715583..102717366,2	K562	blood:
4	chr7:102616176..102618073-chr7:103034545..103036072,2	K562	blood:
5	chr7:102451931..102453738-chr7:102614138..102615717,2	K562	blood:
6	chr7:102616376..102618625-chr7:102696676..102699468,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LRRC17-1	chr7:102613969-102614218	ENSG00000230257
2	lnc-LRRC17-1	chr7:102618828-102618967	ENSG00000230257

No data

Variant related genes	Relation type
FBXL13	TF binding region
NFE4	TF binding region
FBXL13	CpG island
NFE4	CpG island
ENSG00000170632	chromatin interactions
ENSG00000238324	chromatin interactions

Extended variants
information (count: 200 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:200 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564267172	chr7:102613822-102613823	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs544564432	chr7:102613837-102613838	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs151119803	chr7:102613875-102613876	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs184087018	chr7:102613899-102613900	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs186414148	chr7:102613941-102613942	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs375364291	chr7:102613961-102613962	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs545644060	chr7:102613971-102613972	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
8	rs368561576	chr7:102613989-102613990	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
9	rs375812675	chr7:102613991-102613992	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
10	rs369076515	chr7:102613993-102613994	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
11	rs373336858	chr7:102613995-102613996	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
12	rs377698612	chr7:102613997-102613998	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
13	rs371287689	chr7:102614008-102614009	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
14	rs373987346	chr7:102614030-102614031	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
15	rs190878117	chr7:102614032-102614033	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
16	rs548810536	chr7:102614035-102614036	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
17	rs376839670	chr7:102614063-102614064	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
18	rs531224265	chr7:102614087-102614088	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
19	rs370703935	chr7:102614092-102614093	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
20	rs374080339	chr7:102614099-102614100	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
21	rs549350915	chr7:102614117-102614118	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
22	rs367623452	chr7:102614120-102614121	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
23	rs571236777	chr7:102614121-102614122	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
24	rs370049398	chr7:102614122-102614123	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
25	rs373762173	chr7:102614133-102614134	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
26	rs6465886	chr7:102614137-102614138	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs182316080	chr7:102614147-102614148	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
28	rs186683445	chr7:102614169-102614170	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
29	rs375135912	chr7:102614188-102614189	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
30	rs368466489	chr7:102614189-102614190	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
31	rs372032574	chr7:102614194-102614195	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
32	rs375188220	chr7:102614230-102614231	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs536398893	chr7:102614245-102614246	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs566584718	chr7:102614310-102614311	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs192741381	chr7:102614328-102614329	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs375081508	chr7:102614393-102614394	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs537883757	chr7:102614412-102614413	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs75981625	chr7:102614423-102614424	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs141026908	chr7:102614453-102614454	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs545727852	chr7:102614469-102614470	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs530329439	chr7:102614470-102614471	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs183225738	chr7:102614547-102614548	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs188478756	chr7:102614554-102614555	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs527240770	chr7:102614557-102614558	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs543174583	chr7:102614566-102614567	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs193128365	chr7:102614595-102614596	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs531415412	chr7:102614601-102614602	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs113646566	chr7:102614610-102614611	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs184839610	chr7:102614613-102614614	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs146817362	chr7:102614628-102614629	Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Prostate cancer	18632612	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	19907438	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD

Chromatin state (count:49 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:102591000-102619400	Weak transcription	HSMM	muscle
2	chr7:102608800-102618600	Weak transcription	Osteobl	bone
3	chr7:102611800-102615000	Active TSS	K562	blood
4	chr7:102613000-102625600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr7:102613200-102631200	Weak transcription	Primary hematopoietic stem cells	blood
6	chr7:102613600-102614400	Enhancers	H1 Cell Line	embryonic stem cell
7	chr7:102613600-102615800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
8	chr7:102613800-102614000	Enhancers	HUES6 Cell Line	embryonic stem cell
9	chr7:102613800-102614200	Enhancers	Primary monocytes fromperipheralblood	blood
10	chr7:102613800-102614200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
11	chr7:102613800-102614200	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr7:102613800-102615600	Enhancers	HUVEC	blood vessel
13	chr7:102613800-102617000	Weak transcription	Fetal Stomach	stomach
14	chr7:102613800-102618600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr7:102614200-102615200	Weak transcription	HUES6 Cell Line	embryonic stem cell
16	chr7:102614200-102618600	Weak transcription	Primary monocytes fromperipheralblood	blood
17	chr7:102614200-102618800	Weak transcription	Monocytes-CD14+_RO01746	blood
18	chr7:102614400-102615200	Weak transcription	H1 Cell Line	embryonic stem cell
19	chr7:102615000-102618000	Transcr. at gene 5' and 3'	K562	blood
20	chr7:102615200-102615400	Enhancers	H1 Cell Line	embryonic stem cell
21	chr7:102615200-102615600	Enhancers	HUES6 Cell Line	embryonic stem cell
22	chr7:102615600-102618600	Weak transcription	HUVEC	blood vessel
23	chr7:102615600-102619000	Weak transcription	HUES6 Cell Line	embryonic stem cell
24	chr7:102615800-102616600	Enhancers	Primary neutrophils fromperipheralblood	blood
25	chr7:102616600-102617000	Active TSS	Primary neutrophils fromperipheralblood	blood
26	chr7:102616800-102617600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr7:102617000-102618000	Weak transcription	Primary neutrophils fromperipheralblood	blood
28	chr7:102617600-102623600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
29	chr7:102618000-102620000	Genic enhancers	K562	blood
30	chr7:102618000-102620200	Enhancers	Primary neutrophils fromperipheralblood	blood
31	chr7:102618400-102630000	Weak transcription	Right Atrium	heart
32	chr7:102618600-102619200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr7:102618600-102619200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr7:102618600-102619200	Enhancers	Primary monocytes fromperipheralblood	blood
35	chr7:102618600-102619200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
36	chr7:102618600-102619200	Enhancers	Stomach Mucosa	stomach
37	chr7:102618600-102619200	Enhancers	HUVEC	blood vessel
38	chr7:102618600-102619200	Enhancers	NH-A	brain
39	chr7:102618600-102619200	Enhancers	Osteobl	bone
40	chr7:102618600-102619400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr7:102618600-102619400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr7:102618600-102619400	Enhancers	HMEC	breast
43	chr7:102618600-102619400	Enhancers	NHEK	skin
44	chr7:102618600-102619800	Enhancers	Hela-S3	cervix
45	chr7:102618800-102619200	Enhancers	Primary hematopoietic stem cells short term culture	blood
46	chr7:102618800-102619200	Enhancers	Muscle Satellite Cultured Cells	--
47	chr7:102618800-102619200	Active TSS	Adipose Nuclei	Adipose
48	chr7:102618800-102619200	Enhancers	Monocytes-CD14+_RO01746	blood
49	chr7:102618800-102619600	Enhancers	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links